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INTRODUCTION. Information about immunocompromised patients
infected with influenza A virus requiring admission to the ICU is
lacking. The objective of this study was to know the clinical
characteristics of these patients and to identify variables associated
with mortality.
METHODS. A prospective multicenter observational cohort study was
based on data from the GETGAG/SEMICYUC registry (2009–2015)
collected by 148 Spanish ICUs. All patients admitted to the ICU with
the diagnosis of influenza A virus infection were included.
Immunosuppression was defined as any primary immunodeficiency
or immunodeficiency secondary to human immunodeficiency virus
(HIV) infection, active malignancy, immunodeficiency secondary to
radiation treatment or use of cytotoxic drugs or corticosteroids (daily
dose >40 mg of prednisolone or the equivalent for >2 weeks),
immunological disease, solid organ transplant, and haematological
disease. Factors associated with mortality in immunocompromised
patients were assessed by logistic regression analysis.
RESULTS. Of 2315 patients with influenza A infection, 289 (12.5%)
were classified as immunocompromised. Mortality was significantly
higher in immunocompromised patients (47.1% vs 20.1%; p < 0.001).
Severity of illness and the rates of health-care infection, early use of
oseltamivir and administration of corticosteroids were significantly
greater in immunocompromised subjects. In this group of patients,
factor independently associated with mortality were: APACHE II score
(OR =1.09, 95% CI = 1.04-1.13, p < 0.001), stage 3 of acute renal in-
sufficiency (OR = 2.33, 95% CI = 1.69-4.63, p < 0.05), use of vasopres-
sor drugs (OR = 4.69, 95% CI = 2.44-9.03, p < 0.001) and the use of
corticosteroid (OR = 1.89, 95% CI = 1.06-3.37, p < 0.05).
CONCLUSION. Immunocompromised individuals with influenza A
admitted to the ICU have a poorer outcome than patients without
immunocompromise. In this population, we should avoid the use of
corticosteroids because it is independently associated with a higher
mortality.
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INTRODUCTION. Hypoxic hepatitis (HH) (“ischemic hepatitis” or
“shock liver”) is a common cause of hepatic dysfunction in an ICU, is
histologically characterized by centrilobular liver cell necrosis and is
caused by an insufficient oxygen delivery to hepatocytes. Typical for
HH is the sudden, significant rise (>5x ULN) of aspartate
aminotransferase (AST) in response to hemodynamic failure.
OBJECTIVES. The aim of this study was to identify mortality risk
factors of HH using a multivariate prediction model and to assess the
predictive accuracy of 2 existing models (Fuhrmann et al. [2] and
Raurich et al. [3]).
METHODS. The study cohort consisted of 1177 adults with a first
episode of HH (AST >5x ULN) out of 29874 patients admitted to theICU of the Ghent University Hospital (UZG) between January 1st,
2007 and September 21st, 2015. The incidence of HH was 4.2% and
the hospital mortality 42.8%. Further detailed study results are
described in another report [1]. 29 parameters were retrospectively
collected as potential risk factors based on clinical importance. The
association with mortality was studied using logistic regression at the
time of maximal AST value. Predictive accuracy of the models was
assessed by the area under the receiver operating characteristic
curve (AUC), the calibration curve and the Hosmer-Lemeshow (HL)
test. As the 2 existing models were developed in patients with AST
>20x ULN, only this subgroup (n = 460) was used for their validation.
RESULTS. Resp. 8 and 2 risk factors are excluded based on missing
values and correlation. The remaining 19 variables have 1153
complete cases. After a backward elimination procedure, the
multivariate UZG model indicates that age (OR 1.03 per year), cardiac
failure (OR 8.55), septic shock (OR 12.25), hypovolemic shock (OR
7.99), lung embolism (OR 14.04), acute respiratory failure (OR 2.38),
acute-on-chronic respiratory failure (OR 6.68) and mechanical ventila-
tion (OR 2.24) are most significantly (all P < 0.001) associated with
mortality. Additionally, INR (OR 1.27 per unit, P = 0.002), hyperther-
mia (OR 14.58, P = 0.019) and AST (OR 1.01 per 100U/L, P = 0.05) are
significantly associated. pH (OR 0.56 per 0.1) and trombocytes (OR
0.98 per 104/ml) are inversely associated (both P < 0.001). The UZG
model has a good discrimination (AUC 0.79) and shows a good fit
between the observed and expected mortality (HL: P = 0.67). On the
contrary, the models of Raurich et al. and Fuhrmann et al. have a
weak discriminative capacity (AUC 0.59 and 0.67, resp.).
CONCLUSIONS. This is by far the largest single-centre cohort study
of HH described in literature. 7 mortality risk factors associated with
HH are identified. Unlike the 2 existing models, the UZG model has a
good discrimination and calibration.
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INTRODUCTION. Hypoxic hepatitis (HH) (“ischemic hepatitis” or
“shock liver”) is histologically characterized by centrilobular liver cell
necrosis and is caused by an insufficient oxygen delivery to
Fig. 329 (Abstract 1030) ROC curves of MCF for Child-Pugh groups
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significant rise (>5x ULN) of aspartate aminotransferase (AST) in
response to cardiac, circulatory or respiratory failure. Other causes of
AST rise should be excluded before diagnosing HH. Treatment of HH
relies on the prompt correction of the underlying dysfunction.
OBJECTIVES. The aim of this study is to describe the epidemiology,
cause, evolution and outcome of critically ill patients with HH. More
insight may raise more awareness and could result in a faster
diagnosis, which may contribute to a better prognosis.
METHODS. The screened population consists of all adults (n = 29874)
admitted to the ICU at the Ghent University Hospital between January
1st, 2007 and September 21st, 2015. 4012 patients had at least one
episode of AST-levels above 5x ULN. After exclusion of 2835 patients
with another cause of elevated AST-levels (e.g. liver surgery, toxic hepa-
titis, cholangitis,…), a cohort of 1177 first episodes of patients with HH
were identified. These patients are classified by underlying cause of HH.
The most important outcome variable is ICU and hospital mortality.
RESULTS. The incidence of HH is 4.2%. The male/female ratio is 1.5
and the median age is 66 years. The causes of HH are cardiac failure
(40.2%), septic shock (28.3%), post-anesthesia without overt evidence
of an acute cardiac or respiratory event (11.6%), hypovolemic shock
(8.9%), acute respiratory failure (6.0%), acute-on-chronic respiratory
failure (3.1%), pulmonary embolism (1.4%) and hyperthermia (0.5%).
The hospital mortality associated with HH is 42.8%, of which 90.4%
occurred during ICU stay. Pulmonary embolism and septic shock
have the highest (56.2% and 52.9%, resp.) and fastest (median sur-
vival 5.4 and 12.3 days, resp.) mortality. Contrary to previous studies,
patients with a limited rise of AST (5xULN < AST < 10xULN) were also
included. This subgroup contains 439 patients and has a mortality of
26.2%. Another subgroup of 136 patients appeared to develop HH
after major surgery with general anesthesia despite having no prob-
lem during surgery. This subgroup, with still a considerable mortality
of 7.4%, was not described in previous studies.
CONCLUSIONS. This is by far the largest single-centre cohort study
of HH described in literature. With an incidence of 4.2%, HH is a fre-
quent cause of hepatic dysfunction in critically ill patients and is as-
sociated with a high hospital mortality of 42.8%. The principal causes
are acute cardiac disease and septic shock, which include more than
2/3 of all episodes. Clinicians should search actively for an un-
detected underlying hemodynamic or respiratory problem even in
patients with moderately elevated AST values or with AST elevations
after major uncomplicated surgery.
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INTRODUCTION. The severity of liver disease is assessed by scoring
systems which include the conventional coagulation test PT-INR.
However PT-INR is not predictive of bleeding in liver disease and
thromboelastometry has been suggested to give a better overview
of the coagulation system in these patients. It has now been sug-
gested that coagulation as reflected by tromboelastomety, particu-
larly maximum clot firmness (MCF), may also be used for prognostic
purposes in patients with stable chronic liver disease.
OBJECTIVES. The objective of our study was to investigate if
thrombelastometry may discriminate the degree of liver insufficiencyaccording to the scoring systems Child Pugh and Model for End-
stage Liver Disease (MELD).
METHODS. Forty adult patients with stable chronic liver disease of
different etiologies and stages were included in this observational
cross-sectional study. The severity of liver disease was evaluated
using the Child-Pugh score and the MELD score, and blood samples
for biochemistry, conventional coagulation tests and thromboelasto-
metry were collected at the time of the final assessment for liver
transplantation. Statistical comparisons for the studied parameters
with scores of severity were made using Spearman´s correlation test
and receiver operating characteristic (ROC) curves.Child-Pugh score A + B Child-Pugh score CNo. 22 18Child-Pugh score 8(6–9) 11(10–13)MELD ≤16 MELD >17No. 21 19MELD score 13(7–16) 20(17–27)[Number of patients (No). Scores as median (range).]
RESULTS. Spearman's correlation coefficients indicated that the
thromboelastometric parameters did not correlate with Child-Pugh
or MELD scores. The ROC curves of the thromboelastometric parame-
ters could not differentiate advanced stages from early stages of liver
cirrhosis.
CONCLUSIONS. standard thromboelastometry cannot discriminate
the stage of chronic liver disease in patients with severe chronic liver
disease.
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